title: The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
abstract: Type 1 Diabetes (T1D) is an autoimmune disease characterized by the pancreatic infiltration of immune cells resulting in T cell-mediated destruction of the insulin-producing beta cells. The successes of the Non-Obese Diabetic (NOD) mouse model have come in multiple forms including identifying key genetic and environmental risk factors e.g. Idd loci and effects of microorganisms including the gut microbiota, respectively, and how they may contribute to disease susceptibility and pathogenesis. Furthermore, the NOD model also provides insights into the roles of the innate immune cells as well as the B cells in contributing to the T cell-mediated disease. Unlike many autoimmune disease models, the NOD mouse develops spontaneous disease and has many similarities to human T1D. Through exploiting these similarities many targets have been identified for immune-intervention strategies. Although many of these immunotherapies did not have a significant impact on human T1D, they have been shown to be effective in the NOD mouse in early stage disease, which is not equivalent to trials in newly-diagnosed patients with diabetes. However, the continued development of humanized NOD mice would enable further clinical developments, bringing T1D research to a new translational level. Therefore, it is the aim of this review to discuss the importance of the NOD model in identifying the roles of the innate immune system and the interaction with the gut microbiota in modifying diabetes susceptibility. In addition, the role of the B cells will also be discussed with new insights gained through B cell depletion experiments and the impact on translational developments. Finally, this review will also discuss the future of the NOD mouse and the development of humanized NOD mice, providing novel insights into human T1D.
authors.affiliation: Section of Endocrinology, School of Medicine, Yale University, New Haven, CT, USA.
authors.forename: James A
authors.initials: JA
authors.lastname: Pearson
authors.affiliation: Diabetes Research Group, Institute of Molecular & Experimental Medicine, School of Medicine, Cardiff University, Wales, UK.
authors.forename: F Susan
authors.initials: FS
authors.lastname: Wong
authors.affiliation: Section of Endocrinology, School of Medicine, Yale University, New Haven, CT, USA. Electronic address: li.wen@yale.edu.
authors.forename: Li
authors.initials: L
authors.lastname: Wen
mesh_terms: D000818:Animals; D015551:Autoimmunity; D001402:B-Lymphocytes / Q000276:immunology / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000276:immunology* / Q000628:therapy; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology* / Q000628:therapy; D000069196:Gastrointestinal Microbiome / Q000276:immunology; D020022:Genetic Predisposition to Disease; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007113:Immunity, Innate; D007167:Immunotherapy; D007328:Insulin / Q000276:immunology; D050417:Insulin-Secreting Cells / Q000276:immunology*; D051379:Mice; D016688:Mice, Inbred NOD / Q000235:genetics / Q000276:immunology*; D008822:Mice, Transgenic; D053472:Nod Signaling Adaptor Proteins / Q000276:immunology / Q000378:metabolism; D051381:Rats; D011913:Rats, Inbred BB; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D051193:Toll-Like Receptors / Q000276:immunology / Q000378:metabolism
chemical_list: D006680:HLA Antigens; D007328:Insulin; D053472:Nod Signaling Adaptor Proteins; D051193:Toll-Like Receptors
keywords: B cells; Gut microbiota; Humanized mice; NOD; Type 1 diabetes